Hybridoma · 1986 · 13 citations · 9 references
PharmacyBiotechnologyImmunologyAntibody EngineeringImmunotechnologyMonoclonal AntibodiesAntibody CharacterizationAntibody PurificationHybridoma TechnologyManufacturing Of Monoclonal AntibodiesMonoclonal Antibody TechnologyTherapeutic Antibody DevelopmentChimeric Monoclonal AntibodiesHybridoma Cell Line DevelopmentHybridoma Cell LinesHybridoma FormationHybridoma StabilityHybridoma-derived AntibodiesMyeloma Cell LinesSensitization
The stable mouse x human hybridomas were established by cell fusion of a mouse myeloma cell line, a P3-X63-Ag8-653 (P3-653) subclone, with human peripheral blood mononuclear cells (PBMs) from normal volunteers for production of human monoclonal antibody against a predefined, clinically important antigen of viral origin, hepatitis-B surface (HBs) antigen. For successful mouse x human fusions, it was extremely important to preselect volunteers and to sensitize their PBMs by using in vitro sensitization. The resulting mouse x human hybridomas have continuously secreted a relatively high amount of human monoclonal antibodies to HBs antigen over nine months without cloning.
9
John F. Kearney, Andreas Radbruch, B Liesegang et al. · The Journal of Immunology · 1979 · 1.9K citations · Full text
H. Clifford Lane, James H. Shelhamer, H Mostowski et al. · The Journal of Experimental Medicine · 1982 · 71 citations · Full text